Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Els Ankum-Griffioen
AddedFeb 20, 2024
UpdatedMay 1, 2026
Els Ankum-Griffioen

Els Ankum-Griffioen

Board Member, Jdrf

Els Ankum-Griffioen's Career

Jdrf
Jdrf

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Els Ankum-Griffioen's Career

Jdrf
Jdrf
NonprofitNonprofit$3M9111970New York City, NY, US
Board Member· Board

Leadership at Jdrf

Mark Fischer-ColbrieMark Fischer-ColbrieBoard Member
Mike HopkinsMike HopkinsBoard Member
Carol LurieCarol LurieFounder
Keith NilssonKeith NilssonBoard Member
Paul ShapiroPaul ShapiroBoard Member
Aaron KowalskiAaron KowalskiCEO

Similar to Jdrf

Cystic Fibrosis FoundationCystic Fibrosis FoundationNorth Bethesda, MD, USAdvocacy, Researchest. 1955Cystic Fibrosis FoundationNorth Bethesda, MD, US · est. 1955

US-based non-profit, Cystic Fibrosis Foundation, funds research to cure cystic fibrosis.

Nonprofit1.3k
National Kidney FoundationNational Kidney FoundationNew York City, NY, USPatient Supportest. 1950National Kidney FoundationNew York City, NY, US · est. 1950

US-based National Kidney Foundation, Inc. is a leading non-profit health organization.

Nonprofit596
Parent Project Muscular DystrophyParent Project Muscular DystrophyHackensack, NJ, USAdvocacy, Researchest. 1994Parent Project Muscular DystrophyHackensack, NJ, US · est. 1994

US-based nonprofit, Parent Project Muscular Dystrophy, funds research and promotes advocacy for Muscular Dystrophy treatment.

Nonprofit48
Foundation Fighting BlindnessFoundation Fighting BlindnessColumbia, MD, USResearch, Treatmentsest. 1971Foundation Fighting BlindnessColumbia, MD, US · est. 1971

Foundation dedicated to preventing, treating, and curing retinal degenerative diseases.

Nonprofit · $114M98

Els Ankum-Griffioen's Similar Executives & Operators

Julie BornsteinJulie BornsteinBoard Member · RedfinJames SlavetJames SlavetBoard Member · RedfinSelina TobaccowalaSelina TobaccowalaBoard Member · RedfinGlenn KelmanGlenn KelmanBoard Member · RedfinDavid LissyDavid LissyBoard Member · RedfinW Austin LigonW Austin LigonBoard Member · RedfinSteven GolubchikSteven GolubchikBoard Member · Newmark GroupMark MasinterMark MasinterBoard Member · Newmark Group

People Similar to Els Ankum-Griffioen

Giel van GinnekenGiel van GinnekenBoard Member · PhilipsPhil CardmanPhil CardmanBoard Member · ipviveLinda AssanteLinda AssanteBoard Member · Terreno RealtyPaul EsdalePaul EsdaleBoard Member · Institute for Corporate ProductivityPatricia Croft ICD.DPatricia Croft ICD.DBoard Member · Ontario Teachers' Pension PlanEric EubankEric EubankBoard Member · Wake Forest University